IL-26对T细胞介导的皮肤炎症(包括银屑病)的生物学效应
本研究利用人IL-26转基因小鼠在咪喹莫特诱导的银屑病样模型及小鼠接触超敏模型中探讨IL-26的作用。人IL-26转基因小鼠的红斑、血管化和免疫细胞浸润较对照显著增加,皮损中FGF1、FGF2、FGF7显著上调,银屑病患者皮损中同样上调;体外实验显示IL-26刺激角质形成细胞和血管内皮细胞后FGF1、FGF2、FGF7升高,并直接促进血管内皮细胞增殖和管腔形成。作者认为IL-26可能是T细胞介导皮肤炎症(包括银屑病)有前景的治疗靶点。
要点
- 人IL-26转基因小鼠咪喹莫特诱导后红斑较对照显著增加,皮损血管化和免疫细胞浸润明显。
- 咪喹莫特处理的人IL-26转基因小鼠皮损及银屑病患者皮损中FGF1、FGF2、FGF7显著上调。
- IL-26直接作用于血管内皮细胞促进增殖和管腔形成,可能通过蛋白激酶B、细胞外信号调节激酶和NF-κB通路。
核心结论
- IL-26可能通过上调FGF1、FGF2、FGF7并直接促进血管内皮细胞增殖和管腔形成,加重T细胞介导的皮肤炎症;作者认为IL-26可能是包括银屑病在内的T细胞介导皮肤炎症有前景的治疗靶点。
研究设计与样本
- 研究使用人IL-26转基因小鼠,在咪喹莫特诱导的银屑病样小鼠模型和小鼠接触超敏模型中观察IL-26的作用,并进行体外分析。
主要发现
- 每日涂抹咪喹莫特诱导的红斑症状在人IL-26转基因小鼠中较对照大幅增加。
- 人IL-26转基因小鼠皮损中血管化和免疫细胞浸润明显。
- 咪喹莫特处理的人IL-26转基因小鼠皮损和银屑病患者皮损中FGF1、FGF2、FGF7水平显著上调。
- 体外分析显示,IL-26刺激后人间角质形成细胞和血管内皮细胞中FGF1、FGF2、FGF7水平升高。
- IL-26直接作用于血管内皮细胞,促进其增殖和管腔形成,可能通过蛋白激酶B、细胞外信号调节激酶和NF-κB通路。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Psoriasis is a chronic inflammatory skin disease characterized mainly by epidermal hyperplasia, scaling, and erythema; T helper 17 cells have a role in its pathogenesis. Although IL-26, known as a T helper 17 cytokine, is upregulated in psoriatic skin lesions, its precise role is unclear. We investigated the role of IL-26 in the imiquimod-induced psoriasis-like murine model using human IL-26 transgenic mice. Erythema symptoms induced by daily applications of imiquimod increased dramatically in human IL-26 transgenic mice compared with controls. Vascularization and immune cell infiltration were prominent in skin lesions of human IL-26 transgenic mice. Levels of fibroblast growth factor (FGF) 1, FGF2, and FGF7 were significantly upregulated in the skin lesions of imiquimod-treated human IL-26 transgenic mice and psoriasis patients. In vitro analysis demonstrated that FGF1, FGF2, and FGF7 levels were elevated in human keratinocytes and vascular endothelial cells following IL-26 stimulation. Furthermore, IL-26 acted directly on vascular endothelial cells, promoting proliferation and tube formation, possibly through protein kinase B, extracellular signal-regulated kinase, and NF-κB pathways. Moreover, similar effects of IL-26 were observed in the murine contact hypersensitivity model, indicating that these effects are not restricted to psoriasis. Altogether, our data indicate that IL-26 may be a promising therapeutic target in T cell-mediated skin inflammation, including psoriasis.
引用
- Itoh T, Hatano R, Komiya E, et al. Biological Effects of IL-26 on T Cell-Mediated Skin Inflammation, Including Psoriasis. J Invest Dermatol. 2018. PMID: 30423328. doi:10.1016/j.jid.2018.09.037
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。